chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Nasal congestion
Clinical narrative: This spontaneous case reported by a consumer, describes the occurrence of nasal congestion (stuffy nose) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 vaccine) for COVID-19 immunization. Concurrent medical conditions included seasonal allergy. Concomitant products included desmopressin for an unknown indication. On Mar 17, 2021, patient received second dose of mRNA-1273 (Moderna COVID-19 vaccine), unknown route; dosage 1 dosage form. On an unknown date, patient received first dose of mRNA-1273 (Moderna COVID-19 vaccine), unknown route; 1 dosage form. On Mar 17, 2021, patient experienced nasal congestion (stuffy nose). The patient was treated with Flonase (fluticasone propionate) for nasal stuffiness, at an unspecified dose and frequency. At the time of the report, nasal congestion (stuffy nose) outcome: unknown. Patient did not get a stuffy nose from the use of Moderna. However, as per initial document, patient had it before the 2nd dose which confirms that patient had it after the 1st dose. Action taken with the product mRNA-1273 not applicable. Most recent follow-up information incorporated above includes: On May 7, 2021: medical history and clinical information updated.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Rash, Vaccination site pruritus, Vaccination site swelling
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of RASH (Rash all over the body with itching), VACCINATION SITE SWELLING (swollen arm left arm) and VACCINATION SITE PRURITUS (rash witn itching left arm) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced RASH (Rash all over the body with itching), VACCINATION SITE SWELLING (swollen arm left arm) and VACCINATION SITE PRURITUS (rash witn itching left arm). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency. At the time of the report, RASH (Rash all over the body with itching), VACCINATION SITE SWELLING (swollen arm left arm) and VACCINATION SITE PRURITUS (rash witn itching left arm) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not reported. Treatment information in response to events was not provided.   Reporter did not allow further contact
Age: 87.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Fatigue, Headache, Nausea
Clinical narrative: dizziness; headache; fatigue; nausea; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (dizziness), HEADACHE (headache), FATIGUE (fatigue) and NAUSEA (nausea) in an 87-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.    On 10-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Mar-2021, the patient experienced HEADACHE (headache), FATIGUE (fatigue) and NAUSEA (nausea). On 17-Mar-2021, the patient experienced DIZZINESS (dizziness). The patient was treated with MARIJUANA for Headache, at a dose of Marijuana candy bar. At the time of the report, DIZZINESS (dizziness), HEADACHE (headache), FATIGUE (fatigue) and NAUSEA (nausea) had resolved.            No Concomitant medication was received by the patient  The patient  took a marijuana candy bar to help with her headaches.   Reporter did not allow further contact   Most recent FOLLOW-UP information incorporated above includes: On 22-Jul-2021: Outcome of the events was updated to resolved.
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Vaccination site erythema, Vaccination site pain
Clinical narrative: Red welt at the site of injection; Fever; Sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever), VACCINATION SITE PAIN (Sore arm) and VACCINATION SITE ERYTHEMA (Red welt at the site of injection) in a 40-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011A21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No medical history reported.).    On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Mar-2021, the patient experienced PYREXIA (Fever) and VACCINATION SITE PAIN (Sore arm). On 17-Mar-2021, the patient experienced VACCINATION SITE ERYTHEMA (Red welt at the site of injection). At the time of the report, PYREXIA (Fever), VACCINATION SITE PAIN (Sore arm) and VACCINATION SITE ERYTHEMA (Red welt at the site of injection) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter.  Treatment medication was not provided.
Sex: F
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: Rash; This spontaneous case was reported by a consumer and describes the occurrence of RASH (Rash) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 15-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Mar-2021, the patient experienced RASH (Rash). At the time of the report, RASH (Rash) outcome was unknown. Not Provided          Concomitant medications were not reported. Treatment information in response to events was not provided.
Age: 31.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Feeling abnormal, Pain in extremity, Pyrexia
Clinical narrative: fever; Is very tired; Sore Arm; Feels Dirty; Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (fever), FATIGUE (Is very tired), PAIN IN EXTREMITY (Sore Arm), FEELING ABNORMAL (Feels Dirty) and FATIGUE (Fatigue) in a 31-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038A21A) for COVID-19 vaccination.     Concomitant products included LITHIUM, CLOZAPINE, TRAZODONE, PALIPERIDONE (INVEGA [PALIPERIDONE]), PALIPERIDONE (INVEGA [PALIPERIDONE]) and PARACETAMOL (TYLENOL) for an unknown indication.    On 16-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PYREXIA (fever), FATIGUE (Is very tired), PAIN IN EXTREMITY (Sore Arm), FEELING ABNORMAL (Feels Dirty) and FATIGUE (Fatigue). At the time of the report, PYREXIA (fever), FATIGUE (Is very tired), PAIN IN EXTREMITY (Sore Arm), FEELING ABNORMAL (Feels Dirty) and FATIGUE (Fatigue) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment medications were provided   Reporter did not allow further contact
Age: 81.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect route of product administration, Vaccination site pain
Clinical narrative: Subcutaneous tissue of left arm; Pain at injection site (left arm); This spontaneous case was reported by a consumer and describes the occurrence of INCORRECT ROUTE OF PRODUCT ADMINISTRATION (Subcutaneous tissue of left arm) and VACCINATION SITE PAIN (Pain at injection site (left arm)) in an 81-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 07M20A) for COVID-19 vaccination.     No medical history was provided by the reporter.     On 16-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Subcutaneous) 1 dosage form. On 16-Feb-2021, the patient experienced INCORRECT ROUTE OF PRODUCT ADMINISTRATION (Subcutaneous tissue of left arm) and VACCINATION SITE PAIN (Pain at injection site (left arm)). The patient was treated with PARACETAMOL (TYLENOL) for Adverse event, at a dose of one dose. On 16-Feb-2021, INCORRECT ROUTE OF PRODUCT ADMINISTRATION (Subcutaneous tissue of left arm) had resolved. On 19-Feb-2021, VACCINATION SITE PAIN (Pain at injection site (left arm)) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Subcutaneous) was unknown.       No concomitant medication were provided   This case was linked to MOD-2021-047696 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 29-Jul-2021: Follow up received on 29-Jul-2021 contain non-significant information
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: Dyspnoea, Fatigue, Hyperhidrosis, Hypoaesthesia
Clinical narrative: swelling/numbness left side of face; sob; severe sweating; fatigue; This spontaneous case was reported by a consumer and describes the occurrence of HYPOAESTHESIA (swelling/numbness left side of face), DYSPNOEA (sob), HYPERHIDROSIS (severe sweating) and FATIGUE (fatigue) in a 67-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 15-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Feb-2021, the patient experienced HYPOAESTHESIA (swelling/numbness left side of face), DYSPNOEA (sob), HYPERHIDROSIS (severe sweating) and FATIGUE (fatigue). The patient was treated with SALBUTAMOL SULFATE (ALBUTEROL [SALBUTAMOL SULFATE]) at an unspecified dose and frequency and IBUPROFEN at an unspecified dose and frequency. At the time of the report, HYPOAESTHESIA (swelling/numbness left side of face), DYSPNOEA (sob), HYPERHIDROSIS (severe sweating) and FATIGUE (fatigue) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product was not provided by the reporter.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea, Feeling abnormal, Malaise, Myalgia, Nasopharyngitis
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (Feeling lousy/yucky), MALAISE (Not feeling well), DIARRHOEA (Loose Bowels), NASOPHARYNGITIS (Cold symptoms) and PAIN IN EXTREMITY (Sore arm) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event (No medical history reported).    On 06-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Feb-2021, the patient experienced PAIN IN EXTREMITY (Sore arm). On 17-Mar-2021, the patient experienced FEELING ABNORMAL (Feeling lousy/yucky), MALAISE (Not feeling well), DIARRHOEA (Loose Bowels), NASOPHARYNGITIS (Cold symptoms) and MYALGIA (Feeling achy). At the time of the report, FEELING ABNORMAL (Feeling lousy/yucky), MALAISE (Not feeling well), DIARRHOEA (Loose Bowels), NASOPHARYNGITIS (Cold symptoms) and MYALGIA (Feeling achy) had not resolved and PAIN IN EXTREMITY (Sore arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.  No concomitant medications were reported.  Description: The patient mentioned that they were not feeling well despite being scheduled for the second dose of their Moderna COVID-19 vaccine on 17 Mar 2021. She stated she was not feeling well, had loose bowels, was feeling achy, lousy, yucky and had cold symptoms.She mentioned at that time she received first dose she had a little bit of the sore arm symptom.  No treatment information was provided.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (Feeling lousy/yucky), MALAISE (Not feeling well), DIARRHOEA (Loose Bowels), NASOPHARYNGITIS (Cold symptoms) and PAIN IN EXTREMITY (Sore arm) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event (No medical history reported).    On 06-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Feb-2021, the patient experienced PAIN IN EXTREMITY (Sore arm). On 17-Mar-2021, the patient experienced FEELING ABNORMAL (Feeling lousy/yucky), MALAISE (Not feeling well), DIARRHOEA (Loose Bowels), NASOPHARYNGITIS (Cold symptoms) and MYALGIA (Feeling achy). At the time of the report, FEELING ABNORMAL (Feeling lousy/yucky), MALAISE (Not feeling well), DIARRHOEA (Loose Bowels), NASOPHARYNGITIS (Cold symptoms) and MYALGIA (Feeling achy) had not resolved and PAIN IN EXTREMITY (Sore arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.  No concomitant medications were reported.  Description: The patient mentioned that they were not feeling well despite being scheduled for the second dose of their Moderna COVID-19 vaccine on 17 Mar 2021. She stated she was not feeling well, had loose bowels, was feeling achy, lousy, yucky and had cold symptoms.She mentioned at that time she received first dose she had a little bit of the sore arm symptom.  No treatment information was provided.
Sex: F
Vaccine: COVID19
Symptoms: Interchange of vaccine products
Clinical narrative: Mixed mRNA vaccine; This spontaneous case was reported by a pharmacist and describes the occurrence of INTERCHANGE OF VACCINE PRODUCTS (Mixed mRNA vaccine) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No adverse event was reported).    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced INTERCHANGE OF VACCINE PRODUCTS (Mixed mRNA vaccine). At the time of the report, INTERCHANGE OF VACCINE PRODUCTS (Mixed mRNA vaccine) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.; Reporter's Comments: This report refers to a case of (Product storage error  Product administration error  for mRNA-1273, lot #   with no associated Adverse Events.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Lymph node pain, Lymphadenopathy, Pyrexia, Vaccination site inflammation, Vaccination site mass
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE INFLAMMATION (inflammation), VACCINATION SITE MASS (little bumps at injection site), VACCINATION SITE WARMTH (warm to the touch at injection site), LYMPH NODE PAIN (painful lymph nodes of neck on right side) and VACCINATION SITE PRURITUS (itching at injection site) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included ATORVASTATIN CALCIUM (LIPITOR), ESTRADIOL and LOSARTAN POTASSIUM for an unknown indication.    On 08-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Mar-2021, the patient experienced VACCINATION SITE INFLAMMATION (inflammation) and VACCINATION SITE PAIN (tenderness at injection site). On 16-Mar-2021, the patient experienced VACCINATION SITE MASS (little bumps at injection site), VACCINATION SITE WARMTH (warm to the touch at injection site), VACCINATION SITE PRURITUS (itching at injection site) and PYREXIA (slight fever). On 17-Mar-2021, the patient experienced LYMPH NODE PAIN (painful lymph nodes of neck on right side) and LYMPHADENOPATHY (swollen lymph nodes of neck on right side). At the time of the report, VACCINATION SITE INFLAMMATION (inflammation), VACCINATION SITE MASS (little bumps at injection site), VACCINATION SITE WARMTH (warm to the touch at injection site), LYMPH NODE PAIN (painful lymph nodes of neck on right side), VACCINATION SITE PRURITUS (itching at injection site), LYMPHADENOPATHY (swollen lymph nodes of neck on right side), VACCINATION SITE PAIN (tenderness at injection site) and PYREXIA (slight fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication not reported.  Patient did not treated the symptoms.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain, Vaccination site pruritus, Vaccination site warmth
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE INFLAMMATION (inflammation), VACCINATION SITE MASS (little bumps at injection site), VACCINATION SITE WARMTH (warm to the touch at injection site), LYMPH NODE PAIN (painful lymph nodes of neck on right side) and VACCINATION SITE PRURITUS (itching at injection site) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included ATORVASTATIN CALCIUM (LIPITOR), ESTRADIOL and LOSARTAN POTASSIUM for an unknown indication.    On 08-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Mar-2021, the patient experienced VACCINATION SITE INFLAMMATION (inflammation) and VACCINATION SITE PAIN (tenderness at injection site). On 16-Mar-2021, the patient experienced VACCINATION SITE MASS (little bumps at injection site), VACCINATION SITE WARMTH (warm to the touch at injection site), VACCINATION SITE PRURITUS (itching at injection site) and PYREXIA (slight fever). On 17-Mar-2021, the patient experienced LYMPH NODE PAIN (painful lymph nodes of neck on right side) and LYMPHADENOPATHY (swollen lymph nodes of neck on right side). At the time of the report, VACCINATION SITE INFLAMMATION (inflammation), VACCINATION SITE MASS (little bumps at injection site), VACCINATION SITE WARMTH (warm to the touch at injection site), LYMPH NODE PAIN (painful lymph nodes of neck on right side), VACCINATION SITE PRURITUS (itching at injection site), LYMPHADENOPATHY (swollen lymph nodes of neck on right side), VACCINATION SITE PAIN (tenderness at injection site) and PYREXIA (slight fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication not reported.  Patient did not treated the symptoms.
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: Pain, Rash, Skin burning sensation
Clinical narrative: achy; under arm it was rough and burning; rash in her back, rash in back and chest, left arm and elbow; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (achy), SKIN BURNING SENSATION (under arm it was rough and burning) and RASH (rash in her back, rash in back and chest, left arm and elbow) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 044A21A) for COVID-19 vaccination.     Concomitant products included HYDROCHLOROTHIAZIDE, LOSARTAN POTASSIUM (HYZAAR), ATORVASTATIN CALCIUM (LIPITOR), PAROXETINE HYDROCHLORIDE (PAXIL [PAROXETINE HYDROCHLORIDE]), FUROSEMIDE, ACETYLSALICYLIC ACID (ASPRIN), APPLE CIDER VINEGAR, ZINC, MULTIVITAMIN [VITAMINS NOS], ASCORBIC ACID, ROSA CANINA FRUIT (VITAMIN C & ROSEHIP) and VITAMIN B12 NOS for an unknown indication, NIFEDIPINE (ADALAT).    On 13-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Mar-2021, the patient experienced PAIN (achy), SKIN BURNING SENSATION (under arm it was rough and burning) and RASH (rash in her back, rash in back and chest, left arm and elbow). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency. At the time of the report, PAIN (achy), SKIN BURNING SENSATION (under arm it was rough and burning) and RASH (rash in her back, rash in back and chest, left arm and elbow) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The other concomitant medication include electrozole 2.5mg .
Age: 62.0
Sex: M
Vaccine: COVID19
Symptoms: Adverse event, Body temperature fluctuation, Bone pain, Pyrexia
Clinical narrative: fever; bone pain; very strong reaction; temperature goes down but at times it shoots up strongly; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (fever), BONE PAIN (bone pain), ADVERSE EVENT (very strong reaction) and BODY TEMPERATURE FLUCTUATION (temperature goes down but at times it shoots up strongly) in a 62-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002B21A) for COVID-19 vaccination.     No medical history was provided by reporter.  No concomitant medication reported.   On 15-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PYREXIA (fever), BONE PAIN (bone pain), ADVERSE EVENT (very strong reaction) and BODY TEMPERATURE FLUCTUATION (temperature goes down but at times it shoots up strongly). The patient was treated with PARACETAMOL (TYLENOL) at a dose of 500 milligram every four hours. At the time of the report, PYREXIA (fever), BONE PAIN (bone pain), ADVERSE EVENT (very strong reaction) and BODY TEMPERATURE FLUCTUATION (temperature goes down but at times it shoots up strongly) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant product was provided.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Vaccination site erythema, Vaccination site swelling, Vaccination site warmth
Clinical narrative: warm to touch at the injection site; slightly raised at the injection site; 6 inch diameter red area at the injection site; arm was achy; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (arm was achy), VACCINATION SITE WARMTH (warm to touch at the injection site), VACCINATION SITE SWELLING (slightly raised at the injection site) and VACCINATION SITE ERYTHEMA (6 inch diameter red area at the injection site) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 06-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Mar-2021, the patient experienced PAIN IN EXTREMITY (arm was achy). On 12-Mar-2021, the patient experienced VACCINATION SITE WARMTH (warm to touch at the injection site), VACCINATION SITE SWELLING (slightly raised at the injection site) and VACCINATION SITE ERYTHEMA (6 inch diameter red area at the injection site). On 09-Mar-2021, PAIN IN EXTREMITY (arm was achy) had resolved. At the time of the report, VACCINATION SITE WARMTH (warm to touch at the injection site), VACCINATION SITE SWELLING (slightly raised at the injection site) and VACCINATION SITE ERYTHEMA (6 inch diameter red area at the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       No treatment information was provided.  No concomitant product was reported.
Sex: U
Vaccine: COVID19
Symptoms: Heart rate, Heart rate increased
Clinical narrative: Heart Beat Rising; This spontaneous case was reported by a consumer and describes the occurrence of HEART RATE INCREASED (Heart Beat Rising) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced HEART RATE INCREASED (Heart Beat Rising). At the time of the report, HEART RATE INCREASED (Heart Beat Rising) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Heart rate: increased (High) Increased.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Upon in internal review on 24 May 2021, the age was corrected to unknown age. No treatment information was provided.  No concomitant products were reported.   This case was linked to MOD21-055836 (Patient Link).
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Blood glucose increased, Feeling abnormal, Hyperglycaemia, Insomnia
Clinical narrative: high fasting blood sugar; felt off; couldn't sleep; This spontaneous case was reported by a consumer and describes the occurrence of HYPERGLYCAEMIA (high fasting blood sugar), FEELING ABNORMAL (felt off) and INSOMNIA (couldn't sleep) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 029L20A and 014M20A) for COVID-19 vaccination.     The patient's past medical history included Type 2 diabetes mellitus and Anxiety. Concomitant products included METFORMIN for Diabetes.   On 30-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 30-Jan-2021, the patient experienced HYPERGLYCAEMIA (high fasting blood sugar), FEELING ABNORMAL (felt off) and INSOMNIA (couldn't sleep). On 06-Feb-2021, HYPERGLYCAEMIA (high fasting blood sugar), FEELING ABNORMAL (felt off) and INSOMNIA (couldn't sleep) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 31-Jan-2021, Blood glucose increased: 180, 174, 179 (High) fasting blood sugars were "sky high", in the 180's, 174, 179.         Patient normal fasting blood sugar is around 107.  Patient wears a diabetic sensor. Patient noticed her blood sugar increased with both doses of the vaccine.  Treatment information was not provided.   This case was linked to MOD-2021-047827 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 10-May-2021: updated reporter contact details
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration, Product dose omission in error
Clinical narrative: She is scheduled for the second dose on 25Mar2021 (48 days after the first dose); It has been over 36 days and she still did not get the second dose; This spontaneous case was reported by a consumer and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (She is scheduled for the second dose on 25Mar2021 (48 days after the first dose)) and PRODUCT DOSE OMISSION IN ERROR (It has been over 36 days and she still did not get the second dose) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. D13L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Mar-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (She is scheduled for the second dose on 25Mar2021 (48 days after the first dose)) and PRODUCT DOSE OMISSION IN ERROR (It has been over 36 days and she still did not get the second dose). On 17-Mar-2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (She is scheduled for the second dose on 25Mar2021 (48 days after the first dose)) and PRODUCT DOSE OMISSION IN ERROR (It has been over 36 days and she still did not get the second dose) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant products were reported. No treatment information was reported.
Age: 68.0
Sex: M
Vaccine: COVID19
Symptoms: Chest discomfort, Dizziness, Paraesthesia
Clinical narrative: Tingling after 1st dose/Tingling in feet after 1st dose; Chest tightening after 1st dose; Dizzy after 1st dose; This spontaneous case was reported by a consumer and describes the occurrence of PARAESTHESIA (Tingling after 1st dose/Tingling in feet after 1st dose), CHEST DISCOMFORT (Chest tightening after 1st dose) and DIZZINESS (Dizzy after 1st dose) in a 68-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010a21a) for COVID-19 vaccination.     The patient's past medical history included No adverse event. Concurrent medical conditions included Allergy to intravenous contrast media (The patient is allergic to cat scan dye.), Drug allergy (The patient is allergic to the drug Januvia (sitagliptin) which led to shutting down of his kidneys.), Blood pressure high and Diabetes.    On 17-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-Mar-2021, the patient experienced PARAESTHESIA (Tingling after 1st dose/Tingling in feet after 1st dose), CHEST DISCOMFORT (Chest tightening after 1st dose) and DIZZINESS (Dizzy after 1st dose). On 17-Mar-2021, PARAESTHESIA (Tingling after 1st dose/Tingling in feet after 1st dose), CHEST DISCOMFORT (Chest tightening after 1st dose) and DIZZINESS (Dizzy after 1st dose) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medication list was not provided. Treatment information was not provided.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Vaccination site pain
Clinical narrative: fatigue; pain at injection site (left) arm; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (fatigue) and VACCINATION SITE PAIN (pain at injection site (left) arm) in a 50-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Mar-2021, the patient experienced FATIGUE (fatigue) and VACCINATION SITE PAIN (pain at injection site (left) arm). On 06-Mar-2021, VACCINATION SITE PAIN (pain at injection site (left) arm) had resolved. On 07-Mar-2021, FATIGUE (fatigue) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant products were reported.  No treatment information was provided.
Age: 63.0
Sex: U
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: pain in injection site (left); This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (pain in injection site (left)) in a 63-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027K21A) for COVID-19 vaccination.     No Medical History information was reported.    On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Mar-2021, the patient experienced VACCINATION SITE PAIN (pain in injection site (left)). On 12-Mar-2021, VACCINATION SITE PAIN (pain in injection site (left)) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product was included antiviral medication.   Treatment information was not provided.
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: Dizziness, Gait disturbance
Clinical narrative: Extremely dizzy; barely walk to the bathroom without holding on to something.; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Extremely dizzy) and GAIT DISTURBANCE (barely walk to the bathroom without holding on to something.) in a 73-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Mar-2021, the patient experienced DIZZINESS (Extremely dizzy) and GAIT DISTURBANCE (barely walk to the bathroom without holding on to something.). On 07-Mar-2021, DIZZINESS (Extremely dizzy) had resolved. At the time of the report, GAIT DISTURBANCE (barely walk to the bathroom without holding on to something.) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant products were reported.  No treatment information was provided.
Age: 57.0
Sex: M
Vaccine: COVID19
Symptoms: Limb discomfort, Pain in extremity
Clinical narrative: arm has been incredibly sore and painful; having troubles lifting his arm above his head.; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (arm has been incredibly sore and painful) and LIMB DISCOMFORT (having troubles lifting his arm above his head.) in a 57-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 16-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Mar-2021, the patient experienced PAIN IN EXTREMITY (arm has been incredibly sore and painful) and LIMB DISCOMFORT (having troubles lifting his arm above his head.). The patient was treated with PARACETAMOL (TYLENOL) for Paracetamol, at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (arm has been incredibly sore and painful) and LIMB DISCOMFORT (having troubles lifting his arm above his head.) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant products were reported.
Sex: U
Vaccine: COVID19
Symptoms: Accidental exposure to product
Clinical narrative: This spontaneous case was reported by a physician assistant (subsequently medically confirmed) and describes the occurrence of ACCIDENTAL EXPOSURE TO PRODUCT (Accidentally splashed with the Moderna Covid19 vaccine on skin and eyes) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No medical history reported).    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced ACCIDENTAL EXPOSURE TO PRODUCT (Accidentally splashed with the Moderna Covid19 vaccine on skin and eyes). At the time of the report, ACCIDENTAL EXPOSURE TO PRODUCT (Accidentally splashed with the Moderna Covid19 vaccine on skin and eyes) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   This report refers to a case of accidental exposure to product for mRNA-1273 with no associated AEs.; Sender's Comments: This report refers to a case of accidental exposure to product for mRNA-1273
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive
Clinical narrative: Positive Covid test; This spontaneous case was reported by a consumer and describes the occurrence of SARS-COV-2 TEST POSITIVE (Positive Covid test) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was reported.     On 28-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Mar-2021, the patient experienced SARS-COV-2 TEST POSITIVE (Positive Covid test). At the time of the report, SARS-COV-2 TEST POSITIVE (Positive Covid test) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Concomitant  information was  provided. No Treatment information was  provided.
Sex: F
Vaccine: COVID19
Symptoms: Maternal exposure during pregnancy
Clinical narrative: Took Moderna COVID-19 vaccine while pregnant; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of MATERNAL EXPOSURE DURING PREGNANCY (Took Moderna COVID-19 vaccine while pregnant) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Rhesus antibodies.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. Last menstrual period and estimated date of delivery were not provided. On an unknown date, the patient experienced MATERNAL EXPOSURE DURING PREGNANCY (Took Moderna COVID-19 vaccine while pregnant). At the time of the report, MATERNAL EXPOSURE DURING PREGNANCY (Took Moderna COVID-19 vaccine while pregnant) had resolved. Not Provided
Sex: F
Vaccine: COVID19
Symptoms: Headache
Clinical narrative: headache; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (headache) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 17-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced HEADACHE (headache). At the time of the report, HEADACHE (headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Presyncope
Clinical narrative: He felt like fainting; He experienced weakness; A spontaneous report was received from consumer concerning a 65 years old male patient who received Moderna's COVID-19 vaccine (mRNA-1273) and  experienced weakness, he felt like fainting.  The patient's medical history was not reported by the reporter. Concomitant medications taken by the patient was not provided.   On an unknown date, prior to the onset of the event, the patient received his first of two planned doses of mRNA-1273 (Lot number: unknown) through intramuscular route on left arm for prophylaxis of COVID-19 infection.  On an unknown date, on the same day of vaccination, patient experienced weakness and felt like fainting. The symptoms were subsided. Patient had not received any treatment for his symptoms and was not on any medications.  Treatment activities for event was not taken.  Action taken with mRNA-1273 in response to the events was unknown.  The outcome of the events,  weakness and felt like fainting were resolved.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pruritus, Vaccination site rash, Vaccination site warmth
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (area being warm), VACCINATION SITE RASH (rash around injection site), VACCINATION SITE ERYTHEMA (area being red) and VACCINATION SITE PRURITUS (area being  itchy) in a 34-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 ml. On 12-Mar-2021, the patient experienced VACCINATION SITE WARMTH (area being warm), VACCINATION SITE RASH (rash around injection site), VACCINATION SITE ERYTHEMA (area being red) and VACCINATION SITE PRURITUS (area being  itchy). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, VACCINATION SITE WARMTH (area being warm), VACCINATION SITE RASH (rash around injection site), VACCINATION SITE ERYTHEMA (area being red) and VACCINATION SITE PRURITUS (area being  itchy) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant products were reported.
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site erythema
Clinical narrative: dark spot at injection site 6 weeks later; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE ERYTHEMA (dark spot at injection site 6 weeks later) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010M20A) for COVID-19 vaccination.     Concurrent medical conditions included Arthritis.   On 11-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 08-Feb-2021, the patient experienced INJECTION SITE ERYTHEMA (dark spot at injection site 6 weeks later). At the time of the report, INJECTION SITE ERYTHEMA (dark spot at injection site 6 weeks later) outcome was unknown.            Concomitant medications were not reported. Treatment information in response to events was not provided.
Age: 23.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Hyperhidrosis, Nausea, Pain in extremity
Clinical narrative: sore arms; ear ringing; sweating; Chills; nausea; fatigue; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arms), TINNITUS (ear ringing), HYPERHIDROSIS (sweating), CHILLS (Chills) and NAUSEA (nausea) in a 23-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event.    On 25-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Feb-2021, the patient experienced PAIN IN EXTREMITY (sore arms), TINNITUS (ear ringing), HYPERHIDROSIS (sweating), CHILLS (Chills), NAUSEA (nausea) and FATIGUE (fatigue). At the time of the report, PAIN IN EXTREMITY (sore arms), TINNITUS (ear ringing), HYPERHIDROSIS (sweating), CHILLS (Chills), NAUSEA (nausea) and FATIGUE (fatigue) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided by the reporter.  Treatment information was not provided.
Age: 23.0
Sex: F
Vaccine: COVID19
Symptoms: Tinnitus
Clinical narrative: sore arms; ear ringing; sweating; Chills; nausea; fatigue; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arms), TINNITUS (ear ringing), HYPERHIDROSIS (sweating), CHILLS (Chills) and NAUSEA (nausea) in a 23-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event.    On 25-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Feb-2021, the patient experienced PAIN IN EXTREMITY (sore arms), TINNITUS (ear ringing), HYPERHIDROSIS (sweating), CHILLS (Chills), NAUSEA (nausea) and FATIGUE (fatigue). At the time of the report, PAIN IN EXTREMITY (sore arms), TINNITUS (ear ringing), HYPERHIDROSIS (sweating), CHILLS (Chills), NAUSEA (nausea) and FATIGUE (fatigue) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided by the reporter.  Treatment information was not provided.
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Fatigue, Headache, Pain in extremity, Rash
Clinical narrative: rash all over the abdomen; sore arm; really tired; weak; really bad headache; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm), FATIGUE (really tired), ASTHENIA (weak), HEADACHE (really bad headache) and RASH (rash all over the abdomen) in a 32-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002B21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event. Concomitant products included AMFETAMINE ASPARTATE, AMFETAMINE SULFATE, DEXAMFETAMINE SACCHARATE, DEXAMFETAMINE SULFATE (ADDERALL) and SPIRONOLACTONE for an unknown indication.    On 16-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Mar-2021, the patient experienced PAIN IN EXTREMITY (sore arm), FATIGUE (really tired), ASTHENIA (weak) and HEADACHE (really bad headache). On 17-Mar-2021, the patient experienced RASH (rash all over the abdomen). At the time of the report, PAIN IN EXTREMITY (sore arm), FATIGUE (really tired), ASTHENIA (weak), HEADACHE (really bad headache) and RASH (rash all over the abdomen) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment information was not provided.
Sex: U
Vaccine: COVID19
Symptoms: Influenza like illness
Clinical narrative: flu like symptoms; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (flu like symptoms) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No medical history was provided.).    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced INFLUENZA LIKE ILLNESS (flu like symptoms). At the time of the report, INFLUENZA LIKE ILLNESS (flu like symptoms) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was Not Applicable.       No information about concomitant medication was reported.  No information about treatment medication was reported.     Reporter did not allow further contact